Skip to main content
Industry News
Ga-68 DOTATATE PET/MRI may better assess meningioma treatment response

Researchers found that Ga-68 DOTATATE PET/MRI was able to detect 61% malignant progressive and recurrent lesions and 23% low-avid lesions, confirm osseous and parenchymal invasion and improve extent-of-disease visualization without prolonging acquisition times in individuals with clinically suspected or pathology-proven meningioma. The findings, presented at the Radiological Society of North America's annual meeting, led researchers to conclude that Ga-68 DOTATATE may help guide post-treatment meningioma evaluations.

Full Story: